Home / People / Dr. Thomas Hirse
Thomas Hirse

Dr. Thomas Hirse

Partner
Rechtsanwalt

CMS Hasche Sigle
Kasernenstraße 43-45
40213 Duesseldorf
Germany
Languages German, English

Thomas Hirse has particular experience with the legal evaluation of intellectual property in the context of corporate transactions and IPOs. He regularly advises on technology-driven mergers and acquisitions in the life sciences and biotech sector, mechanical and plant engineering as well as automotive industry. Thomas furthermore advises clients across a variety of industry sectors on an ongoing basis on patent and utility patent law, including all related antitrust law aspects and questions related to employee inventions. He has successfully drafted and negiotiated numerous R&D and licence agreements and also represents his clients in international disputes and acts as counsel in arbitration proceedings.

Thomas started his legal career with Linklaters in 2006 and joined CMS in 2007. He has been a partner since 2014.

more less

Education


  • 2005: PhD; thesis on international private law
  • 2003 - 2005: Trainee lawyer at Wuppertal Regional Court
  • 2001 - 2002: Friedrich Naumann Foundation PhD scholar
  • 2001 - 2002: Worked as legal expert for Arbeitsgemeinschaft der Verbraucherverbände e.V. in the context of the legislative process for the reform of the German law of obligations
  • 2000 - 2002: Research assistant to a Higher Regional Court judge and to Prof. Dr. Harald Koch, Chair for Civil Law, Civil Procedure Law, International Private Law and Comparative Law
  • 1995 - 2000: Law studies at the University of Rostock
more less

Publications


  • Schriftenreihe des Max-Planck-Instituts für auslaendisches und internationales Privatrecht, Die Ausweichklausel im Internationalen Privatrecht - Methodentheoretische und -kritische Gedanken zu einer besonderen kollisionsrechtlichen Generalklausel, Mohr Siebeck Tübingen 2007
  • Kothe/Micklitz/Rott/Tonner/Willingmann; Das neue Schuldrecht - Kompaktkommentar, Kommentierung der Regelungen zum Leistungsstoerungs-und Ruecktrittsfolgenrecht, Luchterhand 2003
  • Beitraege zur Neuregelung des Leistungsstoerungsrechts im Rahmen der Schuldrechtsmodernisierung, VuR 2001, p. 99 ff
  • Die Prozessfuehrung durch den Versicherer (zus. mit Prof. Dr. Harald Koch), VersR 2001
  • Anmerkungen und Beitraege zu verschiedenen BGH-Entscheidungen zum Folgekostenstreit bei straßenbaubedingter Verlegung von Versorgungsleitungen in den neuen Bundeslaendern, NJ 2001, p. 459 ff
more less

Feed

Show only
10/09/2020
CMS ad­vises in­vest­ment hold­ing com­pany Armira on sale of bal­list­ic pro­tec­tion...
In­vest­ment hold­ing com­pany Armira has sold all its shares in M-Sich­er­heits­beteili­gun­gen GmbH (Mehler Vario Sys­tem Group) to private equity firm Deutsche...
04 September 2020
Ger­many: Min­istry's draft bill for Pat­ent Law Mod­ern­isa­tion Act in­cludes...
Is this the end of "auto­mat­ic in­junc­tions" for pat­ent in­fringe­ment in Ger­many? On 1 Septem­ber 2020, the Fed­er­al Min­istry of Justice and Con­sumer Pro­tec­tion presen­ted the min­istry's draft bill (Ref­er­enten­ent­wurf)...
03/03/2020
CMS ad­vises Air­bus on the di­vest­ment of PFW Aerospace
An in­ter­na­tion­al CMS team led by part­ner Dr Eck­art Gott­schalk ad­vised Air­bus on all leg­al as­pects of the trans­ac­tion. CMS of­fices in the United King­dom and in Istan­bul (Tur­key) were also in­volved...
26 March 2020
Ger­man Fed­er­al Con­sti­tu­tion­al Court rules against the Uni­fied Pat­ent Court
The Uni­fied Pat­ent Court and Unit­ary Pat­ent Pack­age has re­ceived an­oth­er hit. Will the pro­ject be re­launched soon by a new vote of the Ger­man Bundestag? On 20 March 2020, the Ger­man Fed­er­al Con­sti­tu­tion­al...
28 January 2020
CMS ad­vised GRAPHA-Hold­ing AG on the ac­quis­i­tion of POLY­DATA AG
An in­ter­na­tion­al team of CMS Switzer­land, Aus­tria and Ger­many un­der the lead of Stefan Brunnsch­weiler (CMS Switzer­land) has ad­vised GRAPHA-Hold­ing AG, a single-fam­ily of­fice and hold­ing com­pany for vari­ous in­dus­tri­al activ­it­ies, on the ac­quis­i­tion of all
19 March 2020
Ger­man Con­sti­tu­tion­al Court to an­nounce de­cision on Uni­fied Pat­ent Court...
The Ger­man Fed­er­al Con­sti­tu­tion­al Court has an­nounced on its web­site that it will pub­lish its de­cision re­gard­ing the Ger­man Rat­i­fic­a­tion Act and the con­sti­tu­tion­al com­plaint against the Uni­fied Pat­ent...
23/12/2019
CMS ad­vises Har­ald Quandt In­dus­trieb­eteili­gun­gen on mer­ger of pipe in­spec­tion...
A CMS team headed by lead part­ner Dr Hendrik Hirsch ad­vised HQIB on all leg­al as­pects of the trans­ac­tion. CMS also ad­vised HQIB on struc­tur­ing and set­ting up the in­dus­tri­al hold­ing com­pany...
23 August 2017
Ger­man con­sti­tu­tion­al chal­lenge to UPCA: new back­ground in­form­a­tion
The Ger­man Con­sti­tu­tion­al Court (the “Court”) has stopped the rat­i­fic­a­tion of the Agree­ment on a Uni­fied Pat­ent Court (the “UPCA”) dur­ing pre­lim­in­ary pro­ceed­ings due to a con­sti­tu­tion­al chal­lenge...
06/09/2019
CMS ad­vises in­dus­tri­al hold­ing com­pany Armira on in­vest­ment in chil­dren’s...
A CMS team headed by lead part­ners Dr Hendrik Hirsch and Dr To­bi­as Schneider ad­vised Armira on all as­pects of leg­al due di­li­gence, the con­tract ne­go­ti­ations and the ne­go­ti­ations with the W&I in­surers...
14 July 2017
HIV drug re­ceives pro­vi­sion­al com­puls­ory pat­ent li­cense
On 11 Ju­ly 2017, the Bundes­gericht­shof (Ger­man Fed­er­al Court of Justice, “FCJ”), Ger­many’s highest civil court, up­held the de­cision of the Bundes­pat­ent­gericht (Fed­er­al Pat­ent Court, “FPC”) grant­ing...
13/09/2018
CMS ad­vises Au­gur on sale of Ver­itas Group to La Française
French as­set man­ager Groupe La Française has ac­quired 100% of the shares in the Ver­itas Group, which has as­sets un­der man­age­ment of around EUR 8 bil­lion.
15 June 2017
More bad news for the European Unit­ary Pat­ent: The Fed­er­al Con­sti­tu­tion­al...
The Bundestag and Bundes­rat have passed Ger­man laws on the European pat­ent with unit­ary ef­fect (the “European Unit­ary Pat­ent”) and the Unit­ary Pat­ent Court (the “UPC”). These laws, which still...